|
ZNF222 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.73114864057789E-14 |
| Normal-vs-Stage2 |
1.07119999537275E-08 |
| Normal-vs-Stage3 |
4.71844785465692E-14 |
| Normal-vs-Stage4 |
1.64324109874769E-12 |
| Stage1-vs-Stage2 |
7.153600E-01 |
| Stage1-vs-Stage3 |
1.264260E-02 |
| Stage1-vs-Stage4 |
3.401900E-03 |
| Stage2-vs-Stage3 |
2.023000E-01 |
| Stage2-vs-Stage4 |
4.606100E-02 |
| Stage3-vs-Stage4 |
3.836000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.58839999953831E-07 |
| Normal-vs-Asian |
3.76999999995853E-06 |
| Caucasian-vs-AfricanAmerican |
6.899600E-01 |
| Caucasian-vs-Asian |
7.215800E-02 |
| AfricanAmerican-vs-Asian |
4.347200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.14157638476354E-13 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
7.404000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(41-60Yrs) |
6.0285110237146E-14 |
| Normal-vs-Age(61-80Yrs) |
1.70308211977499E-12 |
| Normal-vs-Age(81-100Yrs) |
1.277410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.537200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.455610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.457600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.229600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.899800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.476400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.10629999999978E-06 |
| Classical-VS-Follicular |
1.136780E-01 |
| Classical-VS-Other |
9.067000E-01 |
| Classical-VS-Normal |
1.63968838506889E-12 |
| Tall-VS-Follicular |
1.130290E-02 |
| Tall-VS-Other |
2.163800E-01 |
| Tall-VS-Normal |
7.7715611723761E-16 |
| Follicular-VS-Other |
6.913800E-01 |
| Follicular-VS-Normal |
2.60249599648432E-11 |
| Other-VS-Normal |
5.137900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.14537285106553E-12 |
| Normal-vs-N1 |
1.26210153439388E-12 |
| N0-vs-N1 |
9.118200E-02 |
|
|
